NCT01387906

Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

Latisse(Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Kenneth Beer · Individual
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to assess efficacy and safety of Latisse (bimatoprost .03% ophthalmic solution) applied to the lateral and medial eyebrows. The primary outcome is a increase in overall eyebrow prominence as measured by at least a 1-grade increase on the Global Eyebrow Assessment (GEyA) scale, from baseline to the end of the treatment which will be day 270 period.

Conditions

• Hypotrichosis

Interventions

Type	Name	Description
DRUG	topical bimatoprost	topical bimatoprost will be applied one drop to each eyebrow each night.

Timeline

• Start date: 2011-03-01
• Primary completion: 2012-03-01
• Completion: 2012-06-01
• First posted: 2011-07-06
• Last updated: 2012-06-15

Locations

1 site across 1 country: United States